Terms ending in 2037
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D940,172 | Display Screen or Portion Thereof with Graphical User Interface for Interactive Guidelines for Multidisciplinary Cancer Treatment Planning In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 10,596,257 | Methods of Treating Cea-Positive Cancers Using PD-1 Axis Binding Antagonists and ANTI-CEA/ANTI-CD3 Bispecific Antibodies In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,526,413 | Bispecific Antibodies Specific for OX40 In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,696,431 | Method for Providing in a Primary Packaging Container a Dried Solid Product Containing an Active Pharmaceutical Ingredient In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,323,094 | Humanized and Affinity Matured Antibodies to FCRH5 and Methods of Use In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,927,116 | Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,689,339 | Novel Pyrrolidine Derivatives In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,745,731 | Recombinant Production Method In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,265,279 | Combinations of LSD1 Inhibitors for Use in the Treatment of Solid Tumors In force · High confidence | Oryzon Genomics, S.A. | In force | High confidence | |
| US 10,508,107 | Morpholine Derivative In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 84 more term ends in 2037 · Pro | |||||
10 of 94 patents shown. Soonest term end first, then patent number.
Pro members see all 94.
8 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.